STOCK TITAN

Solana Company (HSDT) Financials

HSDT
Trailing 12 months to June 30, 2026
Revenue $12.1M +3992.2% YoY
Net Income -$157.3M -640.4% YoY
EPS (Diluted) $53.72 YoY not available
Operating Cash Flow -$26.9M -135.5% YoY
Market Cap $172.5M as of Oct 5, 2026
Price / Sales 14.3x on $12.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 1.0x on $165.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HSDT SEC filings page.

Solana Company (HSDT) reported $12.1M in revenue over the twelve months to Jun 30, 2026, up 3992.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HSDT FY2025

The latest accounts describe a capital-funded asset platform, not a self-financing operating business: assets expanded far faster than revenue.

The FY2025 balance sheet was overwhelmingly equity-dominant: liabilities were only $3.0M against assets of $303.9M. The funding pattern reinforces that structure, with financing providing $449.2M against $426.5M invested, while operations still produced negative cash flow.

Gross margin swung from -11.9% in FY2024 to 91.7% in FY2025, but the latest net loss was $40.9M; the margin improvement therefore did not translate into earnings. This makes asset deployment more informative than sales margin when interpreting the latest results.

A 10.3x current ratio and only $3.0M of liabilities indicate substantial short-term coverage on paper. However, cash conversion remained negative: operating cash flow was -$16.5M while net loss was $40.9M, meaning reported loss included costs not matched one-for-one by current-period cash outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 38 / 100
Financial Health Score 38/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Solana Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
19

Solana Company held $7.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $16.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Solana Company scores 19/100 among other emerging companies.

Dilution
2

Solana Company had 55M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Solana Company scores 2/100 among other emerging companies.

R&D Intensity
11

Solana Company spent $3.5M on research and development in fiscal year 2025, which was 1.4% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Solana Company scores 11/100 among other emerging companies.

Revenue Progress
92

Solana Company reported revenue of $6.0M in fiscal year 2025, against $520K in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Solana Company scores 92/100 among other emerging companies.

Burn Trend
26

Solana Company's operations used $16.5M of cash in fiscal year 2025, against $11.0M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Solana Company scores 26/100 among other emerging companies.

Balance Sheet
77

Solana Company's cash, cash equivalents and investments came to $7.3M at the end of fiscal year 2025, against $3.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Solana Company scores 77/100 among other emerging companies.

Altman Z-Score Safe
30.83

Solana Company scores 30.83, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($172.5M) relative to total liabilities ($3.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Solana Company passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Solana Company reported a net loss of $40.9M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Solana Company reported an operating loss of $243.8M against $635K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.5M
YoY+5774.4%
QoQ-30.2%
5Y CAGR+104.3%

Solana Company generated $2.5M in revenue in Q2 2026. This represents an increase of 5774.4% from the same quarter a year earlier. Against the prior quarter it is down 30.2%.

Net Income
-$30.3M
YoY-207.7%
QoQ+69.7%

Solana Company reported -$30.3M in net income in Q2 2026. This represents a decrease of 207.7% from the same quarter a year earlier. Against the prior quarter it is up 69.7%.

EPS (Diluted)
-$0.38
QoQ+70.8%

Solana Company earned -$0.38 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 70.8%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$3.6M
YoY-40.0%
QoQ-17.0%
5Y CAGR-13.3%
10Y CAGR-7.5%

Solana Company held $3.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
60M
QoQ+3.5%
5Y CAGR+92.0%
10Y CAGR-3.3%

Solana Company had 60M shares outstanding in Q2 2026. Against the prior quarter it is up 3.5%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
97.0%
QoQ+1.9pp
5Y change+91.3pp

Solana Company's gross margin was 97.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is up 1.9 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity
-18.3%
YoY+144.9pp
QoQ+32.2pp

Solana Company's ROE was -18.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 144.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 32.2 percentage points.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

Share Buybacks
$2.3M
QoQ-33.9%

Solana Company spent $2.3M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 33.9%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

HSDT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSDT quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$2.5M+5774.4%$3.6M+7289.8%$5.2M+3339.5%$697K+1266.7%$43K-76.4%$49K-63.7%$152K+13.4%$51K-64.3%
Cost of Revenue$77K-19.8%$180K+48.8%$180K+16.9%$103K-44.9%$96K-18.6%$121K-1.6%$154K+71.1%$187K0.0%
Gross Profit$2.4M+4720.8%$3.4M+4879.2%$5.0M+252500.0%$594K+536.8%-$53K-182.8%-$72K-700.0%-$2K-104.5%-$136K-209.1%
R&D ExpensesN/AN/A$886K-4.1%$858K-20.3%$822K-5.5%$945K+19.9%$924K+42.2%$1.1M+49.2%
SG&A Expenses$11.1M+354.3%$5.2M+73.3%$13.0M+483.4%$4.6M+62.6%$2.4M-0.4%$3.0M+13.7%$2.2M+36.9%$2.9M+30.1%
Operating Income-$32.7M-883.5%-$99.6M-2383.6%-$201.1M-6288.8%-$35.5M-771.0%-$3.3M-1.6%-$4.0M-17.4%-$3.1M-40.1%-$4.1M-29.1%
EBITDAN/AN/AN/AN/A-$3.3M-1.8%-$4.0M-17.7%-$3.1M-40.9%-$4.1M-30.3%
Interest ExpenseN/AN/A$0-100.0%$1K0.0%$628K+12460.0%$6K-25.0%$3K$1K
Income Tax$0$0$0$0$0$0$0$0
Net Income-$30.3M-207.7%-$99.8M-2500.3%$325.5M+8477.2%-$352.8M-9470.5%-$9.8M-510.0%-$3.8M-52.5%-$3.9M-254.9%-$3.7M-0.6%
EPS (Basic)-$0.38+99.5%-$1.30-240.0%$88.29+8755.9%-$32.89-4318.3%-$79.73-16329.0%-$0.38+87.6%-$1.02-6.3%-$0.74+86.4%
EPS (Diluted)-$0.38-$1.30$88.29+8755.9%-$32.89-$79.73-$382.29-$1.02-$744.35
Diluted Shares (Avg)80M77MN/A11M123,33510,039N/A4,952

HSDT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSDT quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$176.1M+2130.5%$200.7M+5660.8%$303.9M+8480.7%$475.9M+8421.4%$7.9M-10.8%$3.5M-39.5%$3.5M-54.0%$5.6M-36.9%
Current Assets$28.7M+268.4%$27.8M+722.4%$31.2M+809.9%$125.7M+2224.5%$7.8M-9.7%$3.4M-38.7%$3.4M-54.0%$5.4M-37.0%
Cash & Equivalents$3.6M-40.0%$4.4M+296.3%$7.3M+569.3%$124.1M+3477.0%$6.1M-4.8%$1.1M-69.5%$1.1M-79.0%$3.5M-47.4%
Short-Term Investments$0$0$0$0$0$0$0$0
InventoryN/AN/A$1.1M+8.2%$1.1M+45.7%$1.1M+39.0%$1.1M+189.8%$1.0M+126.7%$774K+48.6%
Accounts ReceivableN/AN/AN/AN/A$12K-90.1%N/A$70K-40.2%$25K-73.4%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$6.4M+241.0%$2.8M+27.5%$3.0M+21.5%$628.3M+35079.8%$1.9M-25.5%$2.2M-41.6%$2.5M-53.5%$1.8M-69.4%
Current Liabilities$2.2M+19.6%$2.8M+40.3%$3.0M+39.4%$3.1M+109.8%$1.8M-12.3%$2.0M+27.1%$2.2M+15.1%$1.5M+4.3%
Non-Current Liabilities$4.2M+6685.5%$0-100.0%$0-100.0%$625.2M+215476.9%$62K-86.2%$201K-90.8%$320K-90.8%$290K-93.4%
Total Equity$165.6M+2648.8%$197.9M+15360.7%$300.9M+28314.8%-$152.4M-4111.4%$6.0M-4.9%$1.3M-35.5%$1.1M-54.9%$3.8M+25.8%
Retained Earnings-$342.6M-84.8%-$312.4M-78.0%-$212.6M-23.8%-$538.1M-220.8%-$185.4M-13.0%-$175.5M-8.0%-$171.7M-7.3%-$167.8M-5.6%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

HSDT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSDT quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$11.9M-331.3%-$4.8M-36.6%-$6.2M-159.8%-$4.0M-45.9%-$2.8M+4.6%-$3.5M-17.8%-$2.4M-16.9%-$2.8M-13.0%
Depreciation & AmortizationN/AN/AN/AN/A$9K-43.8%$8K-50.0%$12K-42.9%$16K-61.9%
Stock-Based CompensationN/A$90K-85.5%N/A$472K-64.4%$410K+11.7%$622K+55.1%N/A$1.3M+229.3%
Capital ExpendituresN/AN/AN/AN/AN/AN/A$0-100.0%$0-100.0%
Free Cash FlowN/AN/AN/AN/AN/AN/A-$2.4M-16.7%-$2.8M-12.7%
Investing Cash Flow$5.5M$5.5M-$159.1M-$267.4MN/AN/A$0+100.0%$0+100.0%
Financing Cash Flow$5.7M-26.6%-$3.5M-199.1%$48.6M$389.4M+261441.6%$7.7M+37.0%$3.6M+143.1%$0-100.0%-$149K
Share Buybacks$2.3M$3.5MN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

HSDT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSDT quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin97.0%95.0%96.6%+97.9pp85.2%-123.3%-146.9%-1.3%-34.2pp-266.7%
Operating Margin-1293.5%-2751.1%-3845.8%-5086.1%-7725.6%-8185.7%-2070.4%-7980.4%
Net Margin-1197.8%-2756.1%6226.8%-50612.3%-22867.4%-7832.6%-2556.6%-7227.5%
Return on Equity-18.3%+144.9pp-50.4%+249.4pp108.2%+475.1ppN/A-163.2%-137.8pp-299.8%-173.2pp-367.0%-320.4pp-97.0%+24.2pp
Return on Assets-17.2%+107.4pp-49.7%+60.4pp107.1%+216.8pp-74.1%-8.1pp-124.6%-106.4pp-110.2%-66.5pp-109.7%-95.5pp-66.0%-24.6pp
Current Ratio13.31+9.0x9.90+8.2x10.33+8.7x40.03+36.4x4.32+0.1x1.69-1.8x1.58-2.4x3.61-2.4x
Debt-to-Equity0.04-0.3x0.01-1.7x0.01-2.3xN/A0.31-0.1x1.72-0.2x2.34+0.1x0.47-1.5x
Asset Turnover0.010.0x0.020.0x0.020.0x0.000.0x0.010.0x0.010.0x0.040.0x0.010.0x
FCF MarginN/AN/AN/AN/AN/AN/A-1564.5%-5433.3%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Solana Company HSDT FY2025 $6.0M -$40.9M N/A $172.5M 38/100
BIOMERICA INC BMRA FY2026 $4.5M -$3.8M -84.8% $9.9M 44/100
HeartSciences Inc. HSCS FY2026 $4K -$9.1M N/A $20.8M —
STRATA SKIN SCIENCES INC SSKN FY2025 $30.7M -$6.3M -20.4% $1.1M —
DIH HOLDINGS US INC A DHAI FY2025 $62.9M -$8.7M -13.8% $1.6M —
Lifeward Ltd. LFWD FY2025 $22.0M -$19.9M -90.3% $16.6M 47/100

Frequently Asked Questions

What is Solana Company's annual revenue?

Solana Company (HSDT) reported $6.0M in total revenue for fiscal year 2025. This represents a 1057.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Solana Company's revenue growing?

Solana Company (HSDT) revenue grew by 1057.1% year-over-year, from $520K to $6.0M in fiscal year 2025.

Is Solana Company profitable?

No, Solana Company (HSDT) reported a net income of -$40.9M in fiscal year 2025.

Solana Company (HSDT) reported diluted earnings per share of -$1.85 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Solana Company (HSDT) had a gross margin of 91.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Solana Company (HSDT) has a return on equity of -13.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Solana Company (HSDT) recorded an outflow of $16.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Solana Company (HSDT) had $303.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Solana Company (HSDT) invested $3.5M in research and development during fiscal year 2025.

Solana Company (HSDT) had 55M shares outstanding as of fiscal year 2025.

Solana Company (HSDT) had a current ratio of 10.33 as of fiscal year 2025, which is generally considered healthy.

Solana Company (HSDT) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Solana Company (HSDT) had a return on assets of -13.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Solana Company (HSDT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $172.5M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Solana Company (HSDT) trades at 14.3x sales, its market capitalization divided by revenue of $12.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $172.5M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Solana Company (HSDT) has an Altman Z-Score of 30.83, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Solana Company (HSDT) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Solana Company (HSDT) reported a net loss of $40.9M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Solana Company (HSDT) reported an operating loss of $243.8M against $635K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Solana Company (HSDT) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top